Irritable bowel syndrome (IBS) affects approximately 4–10% of the global population and is more common in women and younger adults1 . This chronic disorder of gut-brain interaction causes recurrent abdominal pain and altered bowel habits, significantly impacting quality of life2 . Despite its prevalence, the exact causes of IBS remain unclear, with multiple factors contributing to its development and symptom variability3 .
“IBS is a common, chronic disorder of gut-brain interaction characterized by recurrent abdominal pain and altered bowel habits, including constipation, diarrhea, or both.”
— Rohit R. Nathani, MD, The University of Iowa2
Potential Causes of IBS
Alterations in gut microbiota composition, intestinal motility disturbances, and immune activation are implicated in IBS pathophysiology.
IBS is a multifactorial condition involving complex interactions between the gut and brain, immune system, microbiota, and genetic factors. Understanding these mechanisms helps clarify why symptoms vary and why treatment must be individualized.
IBS is primarily considered a disorder of gut-brain interaction, where communication between the central nervous system (CNS) and the gastrointestinal (GI) tract is altered4 . The gut-brain axis involves bidirectional signaling pathways that regulate GI motility, secretion, and visceral sensation5 . Proper gut-brain communication prevents normal digestive processes from being perceived as painful or uncomfortable4 .
Dysregulation of this axis leads to visceral hypersensitivity, a hallmark of IBS symptoms, causing patients to experience pain or discomfort from stimuli that would not affect others5 . Altered motility patterns, such as accelerated or delayed intestinal transit, are linked to disrupted gut-brain signaling and define IBS subtypes characterized by diarrhea or constipation5 4. Stress, infections, and inflammation can impair gut-brain communication, triggering or worsening symptoms4 .
Dysregulation of the gut-brain axis can cause visceral hypersensitivity, a hallmark of IBS symptoms.
Alterations in the composition and function of gut microbiota are implicated in IBS pathophysiology6 . Patients with IBS often exhibit dysbiosis, a disruption in the balance of intestinal bacteria, fungi, and viruses, which affects gut health and immune responses7 8. These microbial changes can influence intestinal motility, permeability, and sensitivity, contributing to symptom development6 .
Post-infectious IBS, which develops after acute gastroenteritis, highlights the role of microbiota and immune activation in IBS9 . Up to 10% of patients develop IBS following such infections, especially women and those with psychological distress9 . Emerging therapies targeting microbiota modulation, such as probiotics and antibiotics, aim to restore balance and relieve symptoms6 .
IBS patients often have heightened sensitivity of the enteric nervous system, the intrinsic nervous system of the GI tract2 . This hypersensitivity causes exaggerated pain responses to normal gut stimuli like gas or stool distension10 . Nerve endings in the digestive tract become oversensitive, leading to abdominal pain, bloating, and discomfort11 .
This visceral hypersensitivity is linked to abnormal signaling between the gut and brain, amplifying pain perception and contributing to symptom severity5 4. It also explains why some patients experience pain even when no structural abnormalities are present2 .
Low-grade mucosal inflammation and immune activation are observed in many IBS patients, particularly those with post-infectious and diarrhea-predominant IBS5 12. Immune cells such as lymphocytes and eosinophils infiltrate the intestinal mucosa, releasing mediators that affect nerve function and gut motility1 .
This immune response may increase intestinal permeability, allowing luminal antigens to stimulate further inflammation and hypersensitivity13 . The interplay between immune dysfunction and microbiota alterations exacerbates symptoms and maintains the chronic nature of IBS7 .
The most common symptoms of irritable bowel syndrome (IBS) are abdominal pain often related to bowel movements and changes in bowel habits.
— Lin Chang, MD, David Geffen School of Medicine, University of California Los Angeles10
Genetic Factors in IBS
Post-infectious IBS occurs in up to 10% of patients after acute gastroenteritis, with women and those with psychological distress at higher risk.
Genetic predisposition plays a role in IBS susceptibility, although the exact mechanisms remain incompletely understood3 . Family history increases the risk of IBS approximately two- to threefold, indicating a hereditary component14 15. However, genetic factors alone do not fully explain IBS development, as environmental and psychosocial influences are also critical3 .
Several candidate genes have been linked to IBS, including mutations such as in the SCN5A gene, which may affect intestinal ion channels and motility16 . Polygenic inheritance, where multiple genes with small effects combine, is suspected to contribute to IBS risk17 . Additionally, epigenetic modifications influenced by environmental factors may affect gene expression related to IBS18 .
Overlap in genetic susceptibility between IBS and psychiatric conditions like anxiety and depression supports shared pathophysiological pathways involving the gut-brain axis19 . Further research is needed to clarify gene-environment interactions and improve personalized approaches to IBS management18 .
IBS Prevalence and Demographics
IBS affects about 10–15% of adults in the United States, with global prevalence estimated around 11% but varying by region20 142. The condition is more common in women, who have approximately twice the prevalence compared to men14 3. IBS onset typically occurs in young and middle-aged adults, often before age 50, with prevalence declining in older populations3 2.
Epidemiological studies show higher IBS rates among non-Hispanic white populations, although socioeconomic status does not consistently correlate with IBS occurrence3 18. The heterogeneity of IBS symptoms and subtypes contributes to variability in diagnosis and reporting across demographic groups21 .
IBS is a heterogeneous disorder with individual variability in the contribution of different pathophysiological mechanisms.
IBS Risk Factors
Multiple risk factors contribute to the development and exacerbation of IBS, spanning genetic, psychological, and environmental domains. These include:
- Age: IBS is most commonly diagnosed in individuals under 50 years old3 2.
- Sex: Women are about twice as likely to develop IBS as men14 3.
- Family History: Having relatives with IBS increases risk two- to threefold14 15.
- Psychosocial Stress: Early life trauma, anxiety, depression, and other mental health conditions are linked to higher IBS risk19 3.
- Post-Infectious Status: Acute gastroenteritis can trigger IBS in a subset of patients9 .
- Food Sensitivities: Intolerance to fermentable carbohydrates and other dietary triggers may worsen symptoms22 11.
- Lifestyle Factors: Smoking may increase IBS risk; emerging evidence suggests vitamin D status could also play a role1 .
These factors interact in complex ways, with psychosocial stressors influencing gut-brain axis function and immune responses, thereby modulating symptom expression7 19.
Key Takeaways
- IBS is a chronic disorder of gut-brain interaction characterized by abdominal pain and altered bowel habits, affecting up to 10–15% of adults worldwide1 2.
- Dysfunction of the gut-brain axis, including visceral hypersensitivity and motility disturbances, is central to IBS pathophysiology5 4.
- Altered gut microbiota and immune system activation contribute to symptom development and persistence7 6.
- Genetic predisposition increases IBS risk, but environmental and psychosocial factors are also critical14 3.
- Women and younger adults are more commonly affected, with multiple risk factors including stress, infections, and food sensitivities influencing onset and severity14 1922.
